[2]
Leung, P.C. The efficacy of Chinese medicine for SARS: A review of Chinese publications after the crisis. Am. J. Chin. Med., 2007, 35(4), 575-581.
[http://dx.doi.org/10.1142/S0192415X07005077]
[http://dx.doi.org/10.1142/S0192415X07005077]
[3]
http://newsonair.com/News?title=Traditional-Indian-system-of-medicine-Siddha-proves-to-be-effective-in-Covid-19-management
id=391212
[4]
Ministry of Ayush, Government of India, 2020. Homeopathy for prevention of coronavirus infections..
https://pib.gov.in/PressReleasePage.aspx?PRID=1600895.
[5]
Rastogi, S.; Deep, N.P.; Ram, H.S. COVID-19 pandemic: A pragmatic plan for ayurveda intervention. J. Ayurveda Integr. Med., 2020.
[PMID: [https://doi.org/10.1016/j.jaim.2020.04.002] [PMID: 32382220]
[PMID: [https://doi.org/10.1016/j.jaim.2020.04.002] [PMID: 32382220]
Current Pharmaceutical Biotechnology
Title:Touting Traditional Knowledge and Herbal Medicine to Combat and Prevent COVID-19
Volume: 21 Issue: 13
Author(s): Selvaraj Arokiaraj, Savariar Vincent*Dinesh K. Vannam
Affiliation:
- Centre for Environmental Research and Development (CERD), Loyola College, Nungambakkam, Chennai 600 034,India
Export Options
About this article
Cite this article as:
Arokiaraj Selvaraj , Vincent Savariar *, Vannam K. Dinesh , Touting Traditional Knowledge and Herbal Medicine to Combat and Prevent COVID-19, Current Pharmaceutical Biotechnology 2020; 21 (13) . https://dx.doi.org/10.2174/138920102113201007102655
DOI https://dx.doi.org/10.2174/138920102113201007102655 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
6
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Major Drugs Used in COVID-19 Treatment: Molecular Mechanisms, Validation
and Current Progress in Trials
Coronaviruses High Throughput Screening for Bioactive Components from Traditional Chinese Medicine
Combinatorial Chemistry & High Throughput Screening The Emory Chemical Biology Discovery Center: Leveraging Academic Innovation to Advance Novel Targets through HTS and Beyond
Combinatorial Chemistry & High Throughput Screening COVID-19: Could Irisin Become the Handyman Myokine of the 21st Century?
Coronaviruses Recent Advances in Computational Studies on Influenza A Virus M2 Proton Channel
Mini-Reviews in Medicinal Chemistry Chest CT Imaging in the Diagnosis of COVID-19: Rapid Publications are not Equal to Quality of Research
Current Medical Imaging Impacts of Bioinformatics to Medicinal Chemistry
Medicinal Chemistry Chronic Diarrhea and AIDS: Insights into Studies with Non-Human Primates
Current HIV Research Diagnostic Stewardship in Times of COVID-19 Pandemic
Infectious Disorders - Drug Targets Molecular Recognition of Human Angiotensin-Coverting Enzyme I (hACE I) and Different Inhibitors
Current Topics in Medicinal Chemistry Repurposing of RdRp Inhibitors against SARS-CoV-2 through Molecular Docking Tools
Coronaviruses Design and Delivery of Therapeutic siRNAs: Application to MERS-Coronavirus
Current Pharmaceutical Design Nanocarriers in the Delivery of Hydroxychloroquine to the Respiratory System: An Alternative to COVID-19
Current Drug Delivery In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases
Infectious Disorders - Drug Targets COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy
Current Pharmaceutical Design The use of Pseudotyped Coronaviruses for the Screening of Entry Inhibitors: Green Tea Extract Inhibits the Entry of SARS-CoV-1, MERSCoV, and SARS-CoV-2 by Blocking Receptor-spike Interaction
Current Pharmaceutical Biotechnology A Mini-Review on Cardiovascular and Hematological Complications of COVID-19
Coronaviruses COVID-19: A Review on Epidemiology, Clinical Features and Possible Potential Drugs Based on Available Case Studies
Coronaviruses An Updated Review on SARS-CoV-2 Main Proteinase (M<sup>Pro</sup>): Protein Structure and Small-Molecule Inhibitors
Current Topics in Medicinal Chemistry Therapies of Hematological Malignancies: An Overview of the Potential Targets and Their Inhibitors
Current Chemical Biology